Older Adults With NSTEMI-Picking the Patient’s Future:
@JACCJournals
🥸 From "The Garden of Forking Paths" by Jorge Luiz Borges: Dr Albert described the world as an infinite branching possibilities and parallel realities!
😱With @NailaIjaz_MD & @MichaelGNanna
🥸No Summary
Routine Invasive vs Conservative Management of NSTEMI in Elderly Patients: Updated Meta-Analysis of Randomized Trials
In elderly patients with NSTEMI, routine invasive strategy does not improve primary outcomes of all-cause mortality or cardiac-related death but may reduce recurrent myocardial infarction and the need for urgent revascularization.
@DLBHATTMD@DrMarthaGulati@hvanspall@biljana_parapid@AndrewJSauer@AnastasiaSMihai@ankeetbhatt@JACCJournals@ACCinTouch@hvanspall@Hragy
#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare
https://t.co/rySaBmQSHy
🧵/ Late breaking science results from #AHA23 will be posted to this thread at the time of presentation:
SELECT
MINT
ORBITA-2
CRHCP Dementia
POP-HT
KARDIA-1
CARDIA-SSBP
ARTESIA
VERVE-101
ESPRIT
SPEC-AI Nigeria
SPEECH
⬇️
(bookmark this post)
📄 20 studies that Internal Medicine Residents should read in the first year 👇
1/ 🏃♀️ RACE II trial: Lenient resting HR < 110 was non-inferior to a strict HR < 80 in patients with atrial fibrillation.
🧵
In the just concluded @SCAI, our team had the pleasure of presenting our abstracts
We are privileged to have amazing teachers and mentors. #CardioTwitter
https://t.co/Pe0wVuicWF
https://t.co/f1dLzhxQmC
https://t.co/f1dLzhxQmC
@SCAI
These Interventional Cardiologists taking in the sights, sounds of Phoenix and the incredible sessions at #SCAI2023. Heart disease is definitely in trouble!
#BlackMenInMedicine
The final results are in for the #SCAIChampion for the steady hands skills challenge at #SCAI2023. There was a tie between @jameswjohnson and @LinleHouMD with a time of 1 minute and 26 seconds. Congratulations to the winner and all those who participated! 🎊
#AHA22 LBCTs one liners:
1. TRANSFORM-HF: Torsemide was not superior to furosemide in improving survival among patients treated for decompensated HF.
2. DCP: No differences in cardiovascular outcomes between chlorthalidone and HCTZ among elderly veterans with HTN.